CBMG Cellular Biomedicine Group, Inc. gains 16% Sep 15, 2017

Posted By: Rajesh Srivastava - Friday, September 15, 2017

Share

& Comment

Cellular Biomedicine Group Inc., a biomedicine company, develops stem cell therapies for degenerative diseases and cancerous diseases in Greater China. It focuses on developing and marketing cell-based therapies to treat serious chronic and degenerative diseases, such as cancer, osteoarthritis, tissue damage, various inflammatory diseases, and metabolic diseases. The company develops treatments utilizing proprietary cell based technologies, including immune cell therapy for the treatment of a range of cancers; human adipose-derived mesenchymal progenitor cells for the treatment of joint and autoimmune diseases; and tumor cell specific dendritic cell therapy. Cellular Biomedicine Group Inc. was incorporated in 2001 and is headquartered in Cupertino, California. http://www.priceseries.com/trade/CBMG-Cellular-Biomedicine-Group-Inc-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2017082820170915.html

About Rajesh Srivastava

Techism is an online Publication that complies Bizarre, Odd, Strange, Out of box facts about the stuff going around in the world which you may find hard to believe and understand. The Main Purpose of this site is to bring reality with a taste of entertainment

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Copyright © priceSeries Daily Results™ is a registered trademark.

Designed by Templateism. Hosted on Blogger Platform.